RxDoctor Payments Data

Deborah Brown

Pediatric Hematology-Oncology · Houston, TXNPI 1083658009

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 5 manufacturers reported payments, led by Novartis at 29.9% of the total. That places this record below the midpoint for pediatric hematology-oncology clinicians in TX, where the typical reported total is $348.

$373in general payments, 2019–2025

Across 9 payments — averaging $41.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$111
  • Sanofi$110
  • Octapharma USA, Inc.$84
  • AstraZeneca$48
  • Boston Scientific$20
$1,301,838in research payments, 2019–2025

Across 21 payments — averaging $61,992 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Shire North American Group Inc$1.3M
  • Takeda Pharmaceuticals U.S.A., Inc.$35K

What the payments were for

  • Food & beverage$373100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis5$111
Sanofi1$110
Octapharma USA, Inc.1$84
AstraZeneca1$48
Boston Scientific1$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$373 in reported general payments places this provider in the 50th percentile of 235 pediatric hematology-oncology providers in Texas.

See all pediatric hematology-oncology providers in Texas

Other pediatric hematology-oncology in Houston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →